Skip to content

Analysis of Disease Burden, Treatment Patterns, and Prognostic Differences of Different Subtypes of Early/Late-Onset Esophageal Cancer Based on Multi-Databases from a China-US Comparative Perspective and Construction of Survival Prediction Models

Analysis of Disease Burden, Treatment Patterns, and Prognostic Differences of Different Subtypes of Early/Late-Onset Esophageal Cancer Based on Multi-Databases from a China-US Comparative Perspective and Construction of Survival Prediction Models

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600117727
Enrollment
Unknown
Registered
2026-01-28
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Cancer

Interventions

Esophageal adenocarcinoma group aged 15-49 (EA, 15-49 years):None
Esophageal squamous cell carcinoma group aged 15-49 (ESCC, 15-49 years old):None
Esophageal adenocarcinoma group over 50 years old (EA, over 50 years old):None
Esophageal squamous cell carcinoma group over 50 years old (ESCC, over 50 years old):None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with pathologically confirmed esophageal adenocarcinoma (EA) or esophageal squamous cell carcinoma (ESCC). 2.Patients with available information on treatment modalities (including surgery, radiotherapy, chemotherapy, combined therapy, and time from diagnosis to treatment initiation) and follow-up data (including cancer-specific survival [CSS] and overall survival [OS]).

Exclusion criteria

Exclusion criteria: 1.Patients with missing treatment-related data. 2.Patients aged < 15 years at the time of diagnosis. 3.Patients without survival data.

Design outcomes

Primary

MeasureTime frame
Demographic characteristic information (age, gender, marital status, etc.);Clinicopathological information (location of onset, tumor size, tumor grade, tumor stage, histological subtype, etc.);Treatment information (surgery, chemotherapy, radiotherapy, combined treatment regimens, time interval from diagnosis to treatment initiation, etc.);

Countries

China

Contacts

Public ContactLI Jingyao

The First Affiliated Hospital of Army Medical University

522375807@qq.com+86 23 68765833

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026